UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 22 von 78
Datensatz exportieren als...
BibTeX
Prognostic impact of molecular markers in a series of 220 primary glioblastomas
Cancer, 2006-05, Vol.106 (10), p.2218-2223
Houillier, Caroline
Lejeune, Julie
Benouaich‐Amiel, Alexandra
Laigle‐Donadey, Florence
Criniere, Emmanuelle
Mokhtari, Karima
Thillet, Joelle
Delattre, Jean‐Yves
Hoang‐Xuan, Khe
Sanson, Marc
2006
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Houillier, Caroline
Lejeune, Julie
Benouaich‐Amiel, Alexandra
Laigle‐Donadey, Florence
Criniere, Emmanuelle
Mokhtari, Karima
Thillet, Joelle
Delattre, Jean‐Yves
Hoang‐Xuan, Khe
Sanson, Marc
Titel
Prognostic impact of molecular markers in a series of 220 primary glioblastomas
Ist Teil von
Cancer, 2006-05, Vol.106 (10), p.2218-2223
Ort / Verlag
Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Erscheinungsjahr
2006
Quelle
Wiley-Blackwell Journals
Beschreibungen/Notizen
BACKGROUND In contrast to oligodendrogliomas, molecular predictors of prognosis have not been consistently found in glioblastomas. However, genetic studies show that glioblastomas consist of several genetic subtypes and raise the possibility that molecular alterations could be predictive of survival. METHODS A search for loss of heterozygosity (LOH) on chromosome 1p, 9p, 10q, 19q, EGFR (epidermal growth factor receptor), CDK4, and MDM2 (mouse double minute) amplifications, CDKN2A (INK4A/ARF) homozygous deletions, p53 expression, was performed in a series of 220 primary glioblastomas. The molecular alterations were then correlated with each other to identify distinct molecular pathways and with clinical parameters and the course of the disease to identify prognostic markers. RESULTS Nonrandom associations were found between EGFR amplification and LOH10q, LOH9p, and INK4A/ARF deletion, LOH1p and LOH19q, and MDM2 and CDK4 amplification, whereas mutual exclusions were found between p53 expression and EGFR amplification, LOH 9p/INK4A/ARF homozygous deletion, and MDM2 and CDK4 amplification. Age (P = 4.10−5) and performance status (P = .003) were the main predictors of outcome. In contrast, molecular markers were of limited impact: MDM2 amplification correlated with poor outcome on both univariate and multivariate analysis (P = .01) and EGFR amplification with good prognosis on multivariate analysis (P = .02). CONCLUSION Despite their limited prognostic impact, the genetic markers investigated here outline distinct molecular pathways involved in glioblastoma tumorigenesis and warrant broader molecular screening. Cancer 2006. © 2006 American Cancer Society. A molecular and clinical analysis of 220 primary glioblastoma found nonrandom associations and exclusions of molecular markers, suggesting the involvement of distinct pathways. Age and performance status were the main prognostic markers, whereas molecular markers such as EGFR (epidermal growth factor receptor) and MDM2 (mouse double minute) amplifications were of limited impact.
Sprache
Englisch
Identifikatoren
ISSN: 0008-543X
eISSN: 1097-0142
DOI: 10.1002/cncr.21819
Titel-ID: cdi_proquest_miscellaneous_67930078
Format
–
Schlagworte
Adolescent
,
Adult
,
Base Sequence
,
Biological and medical sciences
,
Brain Neoplasms - genetics
,
Brain Neoplasms - mortality
,
Brain Neoplasms - pathology
,
Disease Progression
,
EGFR
,
Female
,
Gene Expression Regulation, Neoplastic
,
Genes, erbB-1 - genetics
,
Genetic Markers
,
glioblastoma
,
Glioblastoma - genetics
,
Glioblastoma - mortality
,
Glioblastoma - pathology
,
Humans
,
Male
,
markers
,
MDM2
,
Medical sciences
,
Middle Aged
,
Molecular Sequence Data
,
Multivariate Analysis
,
Neoplasm Staging
,
Neurology
,
Polymerase Chain Reaction
,
Probability
,
Prognosis
,
Proportional Hazards Models
,
Proto-Oncogene Proteins c-mdm2 - genetics
,
Registries
,
Retrospective Studies
,
Risk Assessment
,
Sensitivity and Specificity
,
Survival Analysis
,
Tumors
,
Tumors of the nervous system. Phacomatoses
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX